Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP216731.RA1XMfegAkPkrL_bNRW_0Akhc0TBqxt0MFs26WpKSuOlk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP216731.RA1XMfegAkPkrL_bNRW_0Akhc0TBqxt0MFs26WpKSuOlk130_assertion type Assertion NP216731.RA1XMfegAkPkrL_bNRW_0Akhc0TBqxt0MFs26WpKSuOlk130_head.
- NP216731.RA1XMfegAkPkrL_bNRW_0Akhc0TBqxt0MFs26WpKSuOlk130_assertion wasGeneratedBy ECO_0000203 NP216731.RA1XMfegAkPkrL_bNRW_0Akhc0TBqxt0MFs26WpKSuOlk130_provenance.
- NP216731.RA1XMfegAkPkrL_bNRW_0Akhc0TBqxt0MFs26WpKSuOlk130_assertion wasDerivedFrom lhgdn-20090331 NP216731.RA1XMfegAkPkrL_bNRW_0Akhc0TBqxt0MFs26WpKSuOlk130_provenance.
- NP216731.RA1XMfegAkPkrL_bNRW_0Akhc0TBqxt0MFs26WpKSuOlk130_assertion SIO_000772 16627808 NP216731.RA1XMfegAkPkrL_bNRW_0Akhc0TBqxt0MFs26WpKSuOlk130_provenance.
- NP216731.RA1XMfegAkPkrL_bNRW_0Akhc0TBqxt0MFs26WpKSuOlk130_assertion evidence source_evidence_literature NP216731.RA1XMfegAkPkrL_bNRW_0Akhc0TBqxt0MFs26WpKSuOlk130_provenance.
- NP216731.RA1XMfegAkPkrL_bNRW_0Akhc0TBqxt0MFs26WpKSuOlk130_assertion description "[In this mouse model of metabolic syndrome, expressing human PON1 inhibited the development of atherosclerosis, probably by reducing the amount of oxidized LDL in plasma and in the plaque, thereby preventing its proatherogenic effects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP216731.RA1XMfegAkPkrL_bNRW_0Akhc0TBqxt0MFs26WpKSuOlk130_provenance.